common diseases

(University of Helsinki) The research group at the Institute for Molecular Medicine Finland has revealed eleven new genetic regions associated with the blood levels of the metabolites, including new loci affecting well-established risk markers for cardiovascular disease and potential biomarkers for type 2 diabetes.

The findings may help in elucidating the processes leading to common diseases. The study will be published in Nature Genetics.

(American Institute of Physics) Eighty years ago, the medical establishment believed cancer was caused by a dysfunction of metabolism, but the idea went out of vogue.

Now, scientists are again looking at metabolism and its role in cancer and other common diseases.

(Children's Hospital of Philadelphia) In findings that may speed the search for disease-causing genes, a new study challenges the prevailing view that common diseases are usually caused by common gene variants (mutations).

Instead, say genetics researchers, the culprits may be numerous rare variants, located in DNA sequences farther away from the original "hot spots" than scientists have been accustomed to look.

The study team successfully tested their approach using real sequencing data from patients with hearing loss.

(Institute of Physics) The future for magentic nanoparticles (mNPs) appears bright With the design of "theranostic" molecules. mNPs could play a crucial role in developing one-stop tools to simultaneously diagnose, monitor and treat a wide range of common diseases and injuries.

(University of Texas M. D. Anderson Cancer Center) While Fanconi anemia is a rare and dangerous disease, new laboratory research at The University of Texas M.

D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly hereditary types of breast cancer.

(University of Leicester) Medical Research Council scientists have made an important advance in understanding the biological processes involved when cells are prompted to die.

The work may help scientists to eventually develop new treatments for the many common diseases and conditions which occur when cell death goes wrong.

TRENTON, N.J. (AP) -- As diabetes is rapidly becoming one of the world's most common diseases, its financial cost is mounting, too, to well over $200 billion a year in the U.S. alone....

CHICAGO (AP) -- Nearly a fourth of widely used new-generation biological drugs that treat several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found....